Back to results
US 6,855,338 B2Granted
Anti-tumor therapies comprising a combination of a cartilage extract and an anti-neoplastic agent providing high efficacy and low toxic side effects
AssigneeLes Laboratoires Aeterna Inc.
InventorEric Dupont
Life of this patent
Estimating the term…
Abstract
This invention described a novel use for cartilage extract, namely a shark cartilage extract, in a combined anti-tumor therapy. The cartilage extract is used in combination with anti-neoplastics. The combined therapy provides for a higher anti-tumor efficacy with no concomitant increase, even better with a decrease, of toxic side effects.
Claims18
An anti-tumor composition comprising
- an anti-tumor amount of anti-neoplastic agent;
- a side effect-reducing amount of a shark cartilage extract;
- and
- a pharmaceutically acceptable carrier.
1 more element
An anti-tumor composition comprising
- a sub-optimal dosage amount of an anti-neoplastic agent;
- a side effect-reducing amount of a shark cartilage extract;
- and
- a pharmaceutically acceptable carrier that is an aqueous solution,
- wherein administration of the anti-tumor composition causes less side effects than administration of a similar composition that does not contain shark cartilage extract.
2 more elements
An anti-tumor composition comprising
- an optimal dosage amount of an anti-neoplastic agent;
- a side effect-reducing amount of a shark cartilage extract;
- and
- a pharmaceutically acceptable carrier that is an aqueous solution,
- wherein administration of the anti-tumor composition causes less side effects than administration of a similar composition that does not contain shark cartilage extract.
2 more elements
An anti-tumor treatment kit comprising
- a first composition comprising a pharmaceutical dosage of an anti-neoplastic agent;
- and
- a second composition comprising a side effect-reducing amount of a shark cartilage extract.
Dependencies are inferred from the claim text.